subscribeSubscribe
Amber Specialty Added to Pfizer’s Limited Distribution Network

Amber Specialty Added to Pfizer’s Limited Distribution Network
BUSINESSWIRE
03 Aug 2022
Share Share
Daiichi Sankyo Announces Late-Breaking Phase 1 Dose Expansion Data

Daiichi Sankyo Announces Late-Breaking Phase 1 Dose Expansion Data
BIOSPACE
17 Sep 2020
Share Share
Three FDA-approved drugs combat COVID in lung cells: report

Three FDA-approved drugs combat COVID in lung cells: report
Arlene Weintraub FIERCEBIOTECH
05 Apr 2020
Share Share
Pfizer Unveils +Ve Results for VIZIMPRO® as 1st line monotherapy in NSCLC

Pfizer Unveils +Ve Results for VIZIMPRO® as 1st line monotherapy in NSCLC
BIOSPECTRUM ASIA
27 Nov 2019
Share Share
NICE shuts down AZ`s Tagrisso—and backs Pfizer rival Vizimpro instead

NICE shuts down AZ`s Tagrisso—and backs Pfizer rival Vizimpro instead
Carly Helfand FIERCE PHARMA
09 Jul 2019
Share Share
NICE OK for life-extending Vizimpro in lung cancer

NICE OK for life-extending Vizimpro in lung cancer
Anna Smith PHARMATIMES
06 Jul 2019
Share Share
Pfizer, ‘never say never’ with big M&A, inks $11.4B Array cancer deal

Pfizer, ‘never say never’ with big M&A, inks $11.4B Array cancer deal
Angus Liu FIERCE PHARMA
18 Jun 2019
Share Share
Pfizer’s Vizimpro given go ahead be European Comission

Pfizer’s Vizimpro given go ahead be European Comission
Maggie Lynch IN-PHARMATECHNOLOGIST
12 Apr 2019
Share Share
Pfizer`s tyrosine kinase inhibitor, Vizimpro gets European approval

Pfizer`s tyrosine kinase inhibitor, Vizimpro gets European approval
PHARMABIZ
04 Apr 2019
Share Share
VIZIMPRO® (dacomitinib) Receives Marketing Authorization in European Union (EU)

VIZIMPRO® (dacomitinib) Receives Marketing Authorization in European Union (EU)
PRESS RELEASE
03 Apr 2019
Share Share